Le Lézard
Classified in: Health, Business
Subjects: NPT, SRI

Blood:Water Celebrates 20 Years $45M Invested in Local Partners in Africa


Nonprofit focused on water and HIV/AIDS projects has developed unique approach to helping solve local crises

NASHVILLE, Tenn., March 22, 2024 /PRNewswire/ -- Blood:Water, an international nonprofit partnering with African-led organizations to end health disparities, celebrates its 20th Anniversary this year. Since 2004, the nonprofit, based in Nashville and founded by the multi-platinum, GRAMMY® Award-winning band, Jars of Clay, and activist Jena Lee Nardella, has raised $45 million to fund projects throughout east and southern Africa.

Working in more than 12 countries to fight the HIV/AIDS epidemic and provide access to clean water, Blood:Water has developed an approach to work in the region that differs from many NGOs and other charitable organizations where only 14% of funding from international donors goes to local organizations in Africa. The organization also has an expanding Nairobi office with a team to help local partners get the necessary resources and tools to grow their organizations.

"At Blood:Water, we've learned over time that the best way to create lasting change in communities, whether here at home or across the world, is to begin with the people closest to the issues themselves," said Jake Smith, Executive Director of Blood:Water. "That's why we work through partners on the ground in communities to learn what they need to be successful and create long-term financial commitments paired with organizational strengthening to ensure their work can be done."

Over the last 20 years Blood:Water has:

This work was made possible by Blood:Water's unique model of organizational strengthening and long-term partnership, which includes an eight-year funding commitment and working with growth-minded community-driven organizations.

"We're proud of the impact we've had on communities through our partners over the last 20 years," said Dan Haseltine, co-founder of Blood:Water. "But there's more work to be done to achieve our goal of ending the water and HIV/AIDS crises in Africa in our lifetimes."

In their 20th year, Blood:Water will continue to shed a light on their unique way of providing funding and support to east and southern Africa and will be working towards raising 10.5 million dollars in the next three years to add six more partners to their portfolio.

About Blood:Water: 
Blood:Water is an international nonprofit that partners with African community-driven organizations to end health disparities caused by the HIV/AIDS and water crises. The organization finds, vets, and partners with organizations in East and Southern Africa that are community-driven and -led, pairing intentional organizational strengthening with flexible financial support.

Success is measured by partners with the essential systems and structures to help increase their reach and deepen their impact. And ultimately, to share in the joy of ending the water & HIV/AIDS crises ? with Blood:Water partners and in this lifetime.

To learn more, visit bloodwater.org.

Media Contact:
Katie Byrd
[email protected]
615-828-7351

SOURCE Blood:Water


These press releases may also interest you

at 20:26
In the news release, Mitsubishi Tanabe Pharma America to Present RADICAVA ORS® (edaravone) Real-World Data at the Professional Society for Health Economics and Outcomes Research 2024 Annual Meeting, issued 03-May-2024 by Mitsubishi Tanabe Pharma...

at 20:00
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

at 19:19
With recent news of dairy cattle in the United States testing positive for the Highly Pathogenic Avian Influenza (HPAI) and reports of fragments of HPAI detected in pasteurized milk sold in the U.S., we understand that Canadians may be concerned...

at 19:01
Butterfly Medical Ltd, an early-stage medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia), is excited to announce the hiring of Patrick MacCarthy as CEO. ...

at 18:33
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement (the "Private Placement") with the issuance of...

at 18:29
Filament Health Corp. (Cboe CA: FH) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, today announced that Chris Wagner has stepped down from his position as Director on the Company's board of directors...



News published on and distributed by: